Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study

Larochelle, Marc R., Bernson, Dana, Land, Thomas, Stopka, Thomas J., Wang, Na, Xuan, Ziming, Bagley, Sarah M., Liebschutz, Jane M., Walley, Alexander Y.·2018·Annals of Internal Medicine

DOI 10.7326/m17-3107

Cited by (1,000)

Items 301–400 of 1,000

Predicting longitudinal service use for individuals with substance use disorders: A latent profile analysis
Erika L. Crable, Mari‐Lynn Drainoni, David K. Jones, Alexander Yale Walley, Jacqueline N. Milton · 2021 · Journal of Substance Abuse Treatment
Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin
Alyssa Shell Tilhou, Jen Birstler, Amelia Baltes, Elizabeth Salisbury‐Afshar, Julia Malicki, Guanhua Chen, Randall Brown · 2022 · Harm Reduction Journal
Racial and ethnic disparities in emergency department–initiated buprenorphine across five health care systems
Wesley C. Holland, Fangyong Li, Bidisha Nath, Molly M. Jeffery, Maria A. Stevens, Edward R. Melnick, James D Dziura, Hazar Khidir, Rachel M. Skains, Gail D’Onofrio et al. · 2023 · Academic Emergency Medicine
Trends in the Prescribing of Buprenorphine for Opioid Use Disorder, 2019-2023
Samuel Thomas Savitz, Maria A Stevens, Bidisha Nath, Gail D’Onofrio, Edward R. Melnick, Molly M. Jeffery · 2024 · Mayo Clinic Proceedings Innovations Quality & Outcomes
Adoption of the 275-Patient Buprenorphine Treatment Waiver for Treating Opioid Use Disorder: A State-Level Longitudinal Analysis
Hannah K. Knudsen, Lewei Allison Lin, Michelle R. Lofwall · 2019 · Substance Abuse
Which patients receive an addiction consult? A preliminary analysis of the INREACH (INpatient REadmission post-Addiction Consult Help) study
Maria J D'Amico, Alexander Yale Walley, Debbie M. Cheng, Leah S. Forman, Danny Regan, Alexandra Yurkovic, Jeffrey H. Samet, Zoe Weinstein · 2019 · Journal of Substance Abuse Treatment
Payment-related barriers to medications for opioid use disorder: A critical review of the literature and real-world application
Bowser, Diana, Bohler, Robert, Davis, Margot T., Hodgkin, Dominic, Horgan, Constance · 2024 · Journal of Substance Use and Addiction Treatment
Emergency department–based efforts to offer medication treatment for opioid use disorder: What can we learn from current approaches?
Maureen T. Stewart, Neto Coulibaly, Daniel Schwartz, Judith Dey, Cindy Lou Parks · 2021 · Journal of Substance Abuse Treatment
Rising Racial Disparities in Opioid Mortality and Undertreatment of Opioid Use Disorder and Mental Health Comorbidities in Virginia
Jacqueline B. Britz, Kristen M. O'Loughlin, Tracey L. Henry, Alicia Richards, Roy T. Sabo, Heather G. Saunders, Sebastian T. Tong, Edward Marshall Brooks, Jason Lowe, Ashley Harrell et al. · 2023 · AJPM Focus
Medications for Opioid Use Disorder for Youth: Patient, Caregiver, and Clinician Perspectives
Connor Buchholz, Lauren Arnold Bell, Safina Adatia, Sarah Mary Bagley, Timothy E. Wilens, Alykhan Nurani, Scott Evan Hadland · 2023 · Journal of Adolescent Health
Incidence of buprenorphine‐precipitated opioid withdrawal in adults with opioid use disorder: A systematic review
Caroline Gregory, Krishan Yadav, Jordyn N. Linders, Lindsey Sikora, Debra A. Eagles · 2024 · Addiction
Pharmacists are missing an opportunity to save lives and advance the profession by embracing opioid harm reduction
Lucas G. Hill, Kirk E. Evoy, Kelly R. Reveles · 2019 · Journal of the American Pharmacists Association
Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder
Ashish Premkumar, William A. Grobman, Mishka Terplan, Emily Stinnett Miller · 2019 · Obstetrics and Gynecology
Racial/Ethnic Differences in the Medical Treatment of Opioid Use Disorders Within the VA Healthcare System Following Non-Fatal Opioid Overdose
Utibe R. Essien, Florentina E. Sileanu, Xinhua Zhao, Jane M. Liebschutz, Carolyn T. Thorpe, Chester B. Good, Maria K. Mor, Thomas R. Radomski, Leslie R. M. Hausmann, Michael J. Fine et al. · 2020 · Journal of General Internal Medicine
Medication Treatment and Health Care Use Among Adolescents With Opioid Use Disorder in Ohio
Laura J. Chavez, Andrea Elena Bonny, Katharine A. Bradley, Gwen T. Lapham, Jennifer N. Cooper, William C. Miller, Deena J. Chisolm · 2020 · Journal of Adolescent Health
Impact of the Opioid Epidemic
Eric J. Lavonas, Cameron Dezfulian · 2020 · Critical Care Clinics
Cost-Effectiveness of an Opioid Abuse–Prevention Program Using the Narcotics Information Management System in South Korea
Siin Kim, Eunji Kim, Hae Sun Suh · 2021 · Value in Health
Buprenorphine prescriber monthly patient caseloads: An examination of 6-year trajectories
Irineo Cabreros, Beth Ann Griffin, Brendan K. Saloner, Adam J. Gordon, Rose Kerber, Bradley D. Stein · 2021 · Drug and Alcohol Dependence
Barriers to accessing medications for opioid use disorder among rural individuals
Anna M. Morenz, Robin M. Nance, L. Sarah Mixson, Judith Feinberg, Gordon Stephen Smith, Philip Todd Korthuis, Mai Tuyet Pho, Wiley D. Jenkins, Peter D. Friedmann, Thomas J. Stopka et al. · 2025 · International Journal of Drug Policy
Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study
Matthew Robbins, Rachel Haroz, Anthony J. Mazzarelli, David H. Clements, Christopher W. Jones, Matthew Salzman · 2021 · Journal of Substance Abuse Treatment
Buprenorphine–naloxone practice and attitudes in 22 Canadian emergency physician groups: a cross-sectional survey
Andrew M. Kestler, Janusz A. Kaczorowski, Kathryn A. Dong, Aaron Michael Orkin, Raoul Daoust, Jessica Moe, Kelsey Van Pelt, Gary Andolfatto, Michelle Klaiman, Justin W. Yan et al. · 2021 · CMAJ Open
To Prescribe or Not to Prescribe?: Barriers and Motivators for Progressing Along Each Stage of the Buprenorphine Training and Prescribing Path
Rachel Winograd, Bridget Coffey, Candice Woolfolk, Claire A. Wood, Vinith Ilavarasan, David B. Liss, Subodh Jain, Erin J. Stringfellow · 2022 · The Journal of Behavioral Health Services & Research
Improving Uptake of Emergency Department-initiated Buprenorphine: Barriers and Solutions
Timothy Kelly, Kathryn F. Hawk, Elizabeth A. Samuels, Reuben J. Strayer, Jason A. Hoppe · 2022 · Western Journal of Emergency Medicine
Pilot randomized controlled trial of a hospital-based substance use treatment and recovery team (START) to improve initiation of medication for alcohol or opioid use disorder and linkage to follow-up care
Allison J. Ober, Karen Chan Osilla, David J. Klein, Lane F. Burgette, Isabel M. Leamon, Mia W. Mazer, Gabrielle Messineo, Stacy Collier, Samuel Korouri, Katherine E. Watkins et al. · 2023 · Journal of Substance Use and Addiction Treatment
Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: A population-based cohort study in Ontario, Canada
Anita Iacono, Tianru Wang, Mina Tadrous, Tonya J. Campbell, Gillian Kolla, Pamela Leece, Beth Ann Sproule, Robert Andrew Kleinman, Jes Besharah, Charlotte Munro et al. · 2023 · Drug and Alcohol Dependence
The fentanyl made me feel like I needed more methadone”: changes in the role and use of medication for opioid use disorder (MOUD) due to fentanyl
Maria Bolshakova, Kelsey A. Simpson, Siddhi S. Ganesh, Jesse L. Goldshear, Cheyenne J. Page, Ricky N. Bluthenthal · 2024 · Harm Reduction Journal
Caring for Patients With Opioid Use Disorder: What Clinicians Should Know About Comorbid Medical Conditions
Deepika E. Slawek, Tiffany Y. Lu, Benjamin T. Hayes, Aaron D. Fox · 2018 · Psychiatric Research and Clinical Practice
Models of Resident Physician Training in Opioid Use Disorders
Ryan Graddy, Anthony J. Accurso, Deepa Rani Nandiwada, Marc Shalaby, Stephen R. Holt · 2019 · Current Addiction Reports
Opioid agonist treatment is highly protective against overdose death among a U.S. statewide population of justice-involved adults
Noa Krawczyk, Ramin Mojtabai, Elizabeth A. Stuart, Michael Fingerhood, Deborah Agus, Brianna Casey Lyons, Jonathan P. Weiner, Brendan K. Saloner · 2020 · The American Journal of Drug and Alcohol Abuse
Voting with their feet: Social factors linked with treatment for opioid use disorder using same-day buprenorphine delivered in California hospitals
Mariah M. Kalmin, David Goodman‐Meza, Erik S. Anderson, Ariana Abid, Melissa Speener, Hannah R. Snyder, Arianna Campbell, Aimee K. Moulin, STEVEN J. SHOPTAW, Andrew A. Herring · 2021 · Drug and Alcohol Dependence
A comparison of office-based buprenorphine treatment outcomes in Bronx community clinics before versus during the COVID-19 pandemic
Chinazo O. Cunningham, Laila Khalid, Yuting Deng, Kristine Torres‐Lockhart, Mariya Masyukova, Shenell Thomas, Chenshu Zhang, Tiffany Y. Lu · 2021 · Journal of Substance Abuse Treatment
Retention in Care as a Quality Measure for Opioid use Disorder
Stephen A. Martin, Lisa M. Chiodo, Amanda Wilson · 2019 · Substance Abuse
Clinical Perspective on Opioids in the Context of Suicide Risk
Paul Sasha Nestadt, Amy S. B. Bohnert · 2020 · FOCUS The Journal of Lifelong Learning in Psychiatry
Relative Cost Differences of Initial Treatment Strategies for Newly Diagnosed Opioid Use Disorder
Marc R. Larochelle, Sarah E. Wakeman, Omid Ameli, Christine E. Chaisson, Jeffrey McPheeters, William H. Crown, Francisca Azocar, Darshak M. Sanghavi · 2020 · Medical Care
Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation
Natrina L Johnson, Sugy Choi, Carolina Herrera · 2021 · Journal of Substance Abuse Treatment
Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?
Vivian Y. O. Au, Tea Rosic, Nitika Sanger, Alannah Hillmer, Caroul Chawar, Andrew Worster, David C. Marsh, Lehana Thabane, Zainab Samaan · 2021 · Harm Reduction Journal
Opioid Use Disorder Diagnosis and Management
Sarah E. Wakeman · 2022 · NEJM Evidence
Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder
Laura Brandt, Mei‐Chen Hu, Ying Liu, Felipe Castillo, Gabriel Odom, Raymond R. Balise, Daniel J. Feaster, Edward V. Nunes, Sean X. Luo · 2023 · American Journal of Psychiatry
Relationship between medication adherence for opioid use disorder and health care costs and health care events in a claims dataset
Shirley X. Liao, Steve Jang, Jordan A. Tharp, Natalie A. Lester · 2023 · Journal of Substance Use and Addiction Treatment
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder
Matisyahu Shulman, Miranda G. Greiner, Hiwot M. Tafessu, Onumara Opara, Kaitlyn Ohrtman, Kenzie M. Potter, Kathryn R. Hefner, Eve Jelstrom, Richard N. Rosenthal, Kevin R. Wenzel et al. · 2024 · JAMA Network Open
Opioid Maintenance Therapy: A Review of Methadone, Buprenorphine, and Naltrexone Treatments for Opioid Use Disorder
David C. Fipps, Tyler Oesterle, Bhanu Prakash Kolla · 2024 · Seminars in Neurology
Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment
Alisa B. Busch, Shelly F. Greenfield, Sharon Reif, Sharon‐Lise T. Normand, Haiden A. Huskamp · 2020 · Journal of Substance Abuse Treatment
Buprenorphine for Opioid Use Disorder in the Emergency Department: A Retrospective Chart Review
Kathy T. LeSaint, Brent Klapthor, Ralph C. Wang, Curtis Geier · 2020 · Western Journal of Emergency Medicine
Care cascade for patients with opioid use disorder and serious injection related infections
Anand Upadhyaya, Laura R. Marks, Evan S. Schwarz, Stephen Y. Liang, Michael J. Durkin, David B. Liss · 2021 · Toxicology Communications
Implementation of a comprehensive hospitalist‐led initiative to improve care for patients with opioid use disorder
Dana Clifton, Noel Ivey, Stephanie Poley, Amy O’Regan, Sudha R. Raman, Nicole Frascino, Shavone Hamilton, Noppon Setji · 2022 · Journal of Hospital Medicine
Using Data to Guide Action in Response to the Public Health Crisis of Opioid Overdoses
Monica Bharel, Dana Bernson, Abigail R. Averbach · 2020 · NEJM Catalyst
Different forms of stigma and rural primary care professionals' willingness to prescribe buprenorphine
Berkeley A. Franz, Lindsay Y. Dhanani, Sean M. Bogart, Cheyenne Fenstemaker, William C. Miller, Orman Trent Hall, Daniel Brook, Vivian Fei-ling Go · 2025 · Journal of Substance Use and Addiction Treatment
Implementation and maintenance of an emergency department naloxone distribution and peer recovery specialist program
Brendan P. Jacka, Hannah N. Ziobrowski, Alexis C Lawrence, Janette B. Baird, Anna E. Wentz, Brandon D. L. Marshall, Rachel Wightman, Michael J. Mello, Francesca L. Beaudoin, Elizabeth A. Samuels · 2021 · Academic Emergency Medicine
The effect of Medicaid expansion on state-level utilization of buprenorphine for opioid use disorder in the United States
Hannah K. Knudsen, Jeanie Hartman, SHARON L. WALSH · 2022 · Drug and Alcohol Dependence
Subsequent Buprenorphine Treatment Following Emergency Physician Buprenorphine Prescription Fills: A National Assessment 2019 to 2020
Bradley D. Stein, Brendan K. Saloner, Rose Kerber, Mark Sorbero, Adam J. Gordon · 2022 · Annals of Emergency Medicine
Unintentional overdoses: understanding the fentanyl landscape and reducing harm
Lauren Arnold Bell, Scott Evan Hadland · 2023 · Current Opinion in Pediatrics
Health Care Provider Stigma Toward Patients With Substance Use Disorders: Protocol for a Nationally Representative Survey
Carrigan Leigh Parish, Daniel J. Feaster, Harold A. Pollack, Viviana E. Horigian, Xiaoming Wang, Petra Jacobs, Margaret R. Pereyra, Christina Drymon, E.M. Allen, Lauren K. Gooden et al. · 2023 · JMIR Research Protocols
Initiation of opioid agonist therapy after hospital visits for opioid poisonings in Ontario
Tina Hu, Daniel McCormack, David Nelson Juurlink, Tonya J. Campbell, Ahmed M. Bayoumi, Pamela Leece, Jessica T. Kent, Tara Gomes · 2023 · Canadian Medical Association Journal
Comparison of Medical Therapy, Valve Surgery, and Percutaneous Mechanical Aspiration for Tricuspid Valve Infective Endocarditis
Sami A El-Dalati, Gregory J. Sinner, Steve Leung, Hassan K. Reda, Michael E. Sekela, Kory Heier, Talal S. Alnabelsi · 2024 · The American Journal of Medicine
Ketamine and Hydroxynorketamine as Novel Pharmacotherapies for the Treatment of Opioid Use Disorders
Anna Onisiforou, Andria Michael, Markos Apostolakis, Elmar Mammadov, Angeliki Mitka, Maria A Kalatta, Morfeas Koumas, Andrea N. Georgiou, Andreas Chatzittofis, Georgia Panayiotou et al. · 2024 · Biological Psychiatry
Systematic Analysis of the Service Process and the Legislative and Regulatory Environment for a Pharmacist-Provided Naltrexone Injection Service in Wisconsin
James H. Ford, Aaron M. Gilson, David A. Mott · 2019 · Pharmacy
Improving transitions of care for patients initiated on buprenorphine for opioid use disorder from the emergency departments in King County, Washington
Callan Elswick Fockele, Herbert C. Duber, Brad Finegood, Sophie C. Morse, Lauren Whiteside · 2021 · Journal of the American College of Emergency Physicians Open
Removal of prior authorization for medication-assisted treatment: impact on opioid use and policy implications in a Medicare Advantage population
Erin A. Ferries, Patrick N. Racsa, Brock Bizzell, Clay Rhodes, Brandon T. Suehs · 2021 · Journal of Managed Care & Specialty Pharmacy
Remotely delivered incentives to promote buprenorphine treatment engagement in out-of-treatment adults with opioid use disorder
August F. Holtyn, Forrest Toegel, Matthew D. Novak, Jeannie‐Marie Leoutsakos, Michael Fingerhood, Kenneth Silverman · 2021 · Drug and Alcohol Dependence
Compulsivity and impulsivity in opioid dependence
Serenella Tolomeo, F. Davey, J. Douglas Steele, Alex Baldacchino · 2021 · Drug and Alcohol Dependence
Implementation of buprenorphine initiation and warm handoff protocols in emergency departments: A qualitative study of Pennsylvania hospitals
Esita Patel, Keisha T. Solomon, Haneefa T. Saleem, Brendan K. Saloner, Tracy Pugh, Eric G. Hulsey, Elli Leontsini · 2021 · Journal of Substance Abuse Treatment
County social isolation and opioid use disorder among older adults: A longitudinal analysis of Medicare data, 2013–2018
Tse‐Chuan Yang, Carla M. Shoff, Seulki Kim, Benjamín A. Shaw · 2022 · Social Science & Medicine
Development of an intravenous low-dose buprenorphine initiation protocol
Lindsay A. Jablonski, Alia Bodnar, Rosalyn Walker Stewart · 2022 · Drug and Alcohol Dependence
Elective Naloxone-Induced Opioid Withdrawal for Rapid Initiation of Medication-Assisted Treatment of Opioid Use Disorder
Reid H. Phillips, Matthew Salzman, Rachel Haroz, Rachel Rafeq, Anthony J. Mazzarelli, Alexis Pelletier‐Bui · 2019 · Annals of Emergency Medicine
Peer Providers and Linkage with Buprenorphine Care after Hospitalization: A Retrospective Cohort Study
Helen E. Jack, Eric Denisiuk, Brett A. Collins, Dan Stephens, Kendra L. Blalock, Jared Wilson Klein, Elenore Patterson Bhatraju, Joseph O. Merrill, Kevin A. Hallgren, Judith I. Tsui · 2022 · Substance Abuse
An evaluation of the association between specific post‐overdose care services in emergency departments and subsequent treatment engagement
Laura C. Chambers, Benjamin D. Hallowell, Elizabeth A. Samuels, Mackenzie M. Daly, Janette B. Baird, Francesca L. Beaudoin · 2023 · Journal of the American College of Emergency Physicians Open
Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment
Bradley D. Stein, Brendan K. Saloner, Olivia K. Golan, Barbara Andraka‐Christou, Christina M. Andrews, Andrew W. Dick, Corey S. Davis, Flora Sheng, Adam J. Gordon · 2023 · JAMA Health Forum
Independent community pharmacists’ attitudes and intentions toward dispensing buprenorphine/naloxone for opioid use disorder
Rana Zalmai, Lucas G. Hill, Lindsey J. Loera, Quinn Mosgrove, Carolyn M. Brown · 2023 · Journal of the American Pharmacists Association
Experiences of Aging with Opioid Use Disorder and Comorbidity in Opioid Treatment Programs: A Qualitative Analysis
Benjamin H. Han, Mirella A. Orozco, Mari Miyoshi, Heidi Doland, Alison A. Moore, Katie Fitzgerald Jones · 2024 · Journal of General Internal Medicine
Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts
Simeon D. Kimmel, Alexander Yale Walley, Laura Forsberg White, Shapei Yan, Christine E. Grella, Adam Majeski, Michael D. Stein, Amy L. Bettano, Dana Bernson, Mari‐Lynn Drainoni et al. · 2024 · JAMA Network Open
Emergency Clinician Buprenorphine Initiation, Subsequent Prescriptions, and Continuous Prescriptions
Annette M. Dekker, David L. Schriger, Andrew A. Herring, Elizabeth A. Samuels · 2025 · JAMA
Retention and dropout from sublingual and extended-release buprenorphine treatment: A comparative analysis of data from a nationally representative sample of commercially-insured people with opioid use disorder in the United States
Roman Ivasiy, Lynn M. Madden, Kimberly Johnson, Eteri Machavariani, Bachar Ahmad, David Oliveros, Jiale Tan, Natalie Kil, Frederick Lewis Altice · 2025 · International Journal of Drug Policy
Neurologic, Cognitive, and Behavioral Consequences of Opioid Overdose: a Review
Justin Sup Hong, María Teresa Cabero Morán, Lisa A. Eaton, Lori M. Grafton · 2019 · Current Physical Medicine and Rehabilitation Reports
Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder
Caleb J. Banta‐Green, Jason R. Williams, Jeanne M. Sears, Anthony S. Floyd, Judith I. Tsui, Theresa J. Hoeft · 2019 · Drug and Alcohol Dependence
Hospital Use Declines After Implementation Of Virginia Medicaid’s Addiction And Recovery Treatment Services
Andrew J. Barnes, Peter James Cunningham, Lauryn Saxe-Walker, Erin Britton, Flora Sheng, Melanie Boynton, Ke’Shawn Harper, Ashley Harrell, Chethan Bachireddy, Ellen Montz et al. · 2020 · Health Affairs
Economic Evaluation of Interventions to Address Opioid Misuse: A Systematic Review of Methods Used in Simulation Modeling Studies
Carolina Barbosa, William N. Dowd, Gary A. Zarkin · 2020 · Value in Health
The Number Needed to Prescribe — What Would It Take to Expand Access to Buprenorphine?
Elisabeth A. Poorman · 2021 · New England Journal of Medicine
Patterns of patient discontinuation from buprenorphine/naloxone treatment for opioid use disorder: A study of a commercially insured population in Massachusetts
Md Mahmudul Hasan, Md. Noor‐E‐Alam, Prathamesh Mohite, Md Saiful Islam, Alicia Modestino, Alyssa M. Peckham, Leonard D. Young, Gary J. Young · 2021 · Journal of Substance Abuse Treatment
Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use–Associated Infective Endocarditis
Joëlla W. Adams, Alexandra A. Savinkina, James C. Hudspeth, Mam Jarra Gai, Raagini Jawa, Laura R. Marks, Benjamin Paul Linas, Alison Hill, Jason Flood, Simeon D. Kimmel et al. · 2022 · JAMA Network Open
Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study
Lara Nicole Coughlin, Devin C Tomlinson, Lan Zhang, H. Myra Kim, Madeline C. Frost, Gabriela Kattan Khazanov, James R. McKay, Dominick DePhilippis, Lewei Allison Lin · 2025 · American Journal of Psychiatry
Universal screening for substance use by Peer Support Specialists in the Emergency Department is a pathway to buprenorphine treatment
Alex K. Gertner, Kate Roberts, Grayson Bowen, Brenda L. Pearson, Robyn Jordan · 2021 · Addictive Behaviors Reports
Improving access to care via psychiatric clinical pharmacist practitioner collaborative management of buprenorphine for opioid use disorder
Haley E. Pals, Jeffrey P. Bratberg · 2022 · Journal of the American Pharmacists Association
County-level sociodemographic differences in availability of two medications for opioid use disorder: United States, 2019
Brian Corry, Natasha L. Underwood, Laura J. Cremer, Cherie R. Rooks-Peck, Christopher McCall Jones · 2022 · Drug and Alcohol Dependence
Access to Medications for Opioid Use Disorder in Rural Versus Urban Veterans Health Administration Facilities
Jessica J. B. Wyse, Sarah Shull, Stephan Lindner, Benjamin J. Morasco, Adam J. Gordon, Kathleen Ferguson Carlson, Philip Todd Korthuis, Sarah S. Ono, Joseph G. Liberto, Travis I. Lovejoy · 2023 · Journal of General Internal Medicine
Disparities in Emergency Department Naloxone and Buprenorphine Initiation
Joan Papp, Charles L. Emerman · 2023 · Western Journal of Emergency Medicine
Association of random and observed urine drug screening with long-term retention in opioid treatment programs
Pryce S. Michener, Alexander B. Knee, Donna Wilson, Esther Boama-Nyarko, Peter D. Friedmann · 2023 · Drug and Alcohol Dependence
Availability of Medications for Opioid Use Disorder in Community Mental Health Facilities
Jonathan Cantor, Beth Ann Griffin, Barbara Levitan, Sapna J. Mendon, Bradley D. Stein, Sarah B. Hunter, Allison J. Ober · 2024 · JAMA Network Open
Prevalence of fentanyl exposure and knowledge regarding the risk of its use among emergency department patients with active opioid use history at an urban medical center in Baltimore, Maryland
Hanh Bach, V. Jenkins, Ali Aledhaim, Siamak Moayedi, Stephen M. Schenkel, Hong Kim · 2019 · Clinical Toxicology
Addressing the context and consequences of substance use, misuse, and dependence: A global imperative
Alexander C. Tsai, Margarita M. Alegria, Steffanie A. Strathdee · 2019 · PLoS Medicine
Assessing Medical Student Interest in Training About Medications for Opioid Use Disorder: A Pilot Intervention
Jennifer Thomas, Stephanie Slat, Gregory M. Woods, Kristen Cross, Colin Macleod, Pooja Lagisetty · 2020 · Journal of Medical Education and Curricular Development
College students’ perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities
Barbara Andraka‐Christou, Thuy Dieu Nguyen, Shana Harris, Jody Lyneé Madeira, Rachel Totaram, Olivia K. Golan, Danielle N. Atkins, Jason A. Ford · 2020 · The American Journal of Drug and Alcohol Abuse
Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment
Kristi C. Hill, Laura Nussdorf, Julia Mount, Rachel Silk, Chloe Gross, David Sternberg, Phyllis Bijole, Miriam Jones, Randy Kier, Dana McCullough et al. · 2021 · Journal of Addiction Medicine
Characteristics and Outcomes of Hospitalizations and Readmissions for Opioid Dependence and Overdose: Nationally Representative Data
Sarah Grzebinski, Laura Katherine Stein, Mandip S. Dhamoon · 2020 · Substance Abuse
Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy
Jennie Broders Jarrett, Jeffrey P. Bratberg, Anne L. Burns, Gerald Cochran, Bethany A. DiPaula, Anna Legreid Dopp, Abigail T. Elmes, Traci Craig Green, Lucas G. Hill, Felicity A. E. Homsted et al. · 2023 · Substance Abuse
Medication Initiation, Patient-directed Discharges, and Hospital Readmissions Before and After Implementing Guidelines for Opioid Withdrawal Management
Jillian H. Zavodnick, Nicolette M. Heinsinger, Angelo C. Lepore, Robert C. Sterling · 2022 · Journal of Addiction Medicine
Implementing syringe services programs within the Veterans Health Administration: facility experiences and next steps
Tessa Rife, Elizabeth Dinges, Minh Quang Ho · 2022 · Journal of the American Pharmacists Association
Naltrexone Compared With Buprenorphine or Methadone in Pregnancy
Sreevalli Atluru, Alyssa Bruehlman, Porcia Vaughn, Charles W. Schauberger, Marcela Carolina Smid · 2024 · Obstetrics and Gynecology
Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals
Berkeley A. Franz, Lindsay Y. Dhanani, Orman Trent Hall, Daniel Brook, Cheyenne Fenstemaker, Janet E. Simon, William C. Miller · 2024 · Addiction Science & Clinical Practice
“They talked to me like I was dirt under their feet:” Treatment and withdrawal experiences of incarcerated pregnant people with opioid use disorder in four U.S. states
Carolyn Sufrin, Tali Ziv, Lauren Dayton, Carl Asher Latkin, Camille T. Kramer · 2024 · SSM - Qualitative Research in Health
Comparative effectiveness of extended‐release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients
Rachael K. Ross, Edward V. Nunes, Mark Olfson, Matisyahu Shulman, Noa Krawczyk, Elizabeth A. Stuart, Kara E. Rudolph · 2024 · Addiction